Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Postexposure prophylaxis for influenza in pediatric wards oseltamivir or zanamivir after rapid antigen detection.

Shinjoh M, Takano Y, Takahashi T, Hasegawa N, Iwata S, Sugaya N.

Pediatr Infect Dis J. 2012 Nov;31(11):1119-23. doi: 10.1097/INF.0b013e318260265a.

PMID:
22634596
2.

Effect of oseltamivir, zanamivir or oseltamivir-zanamivir combination treatments on transmission of influenza in households.

Carrat F, Duval X, Tubach F, Mosnier A, Van der Werf S, Tibi A, Blanchon T, Leport C, Flahault A, Mentré F; BIVIR study group.

Antivir Ther. 2012;17(6):1085-90. doi: 10.3851/IMP2128. Epub 2012 Jun 7.

PMID:
22910171
3.

Antiviral therapy of influenza.

Englund JA.

Semin Pediatr Infect Dis. 2002 Apr;13(2):120-8. Review.

PMID:
12122950
4.

Oseltamivir for influenza postexposure prophylaxis: economic evaluation for children aged 1-12 years in the U.S.

Talbird SE, Brogan AJ, Winiarski AP.

Am J Prev Med. 2009 Nov;37(5):381-8. doi: 10.1016/j.amepre.2009.08.012.

PMID:
19840692
5.

Comparison of the clinical effectiveness of oseltamivir and zanamivir against influenza virus infection in children.

Sugaya N, Tamura D, Yamazaki M, Ichikawa M, Kawakami C, Kawaoka Y, Mitamura K.

Clin Infect Dis. 2008 Aug 1;47(3):339-45. doi: 10.1086/589748.

PMID:
18582202
6.

Clinical effectiveness of oseltamivir and zanamivir for treatment of influenza A virus subtype H1N1 with the H274Y mutation: a Japanese, multicenter study of the 2007-2008 and 2008-2009 influenza seasons.

Kawai N, Ikematsu H, Hirotsu N, Maeda T, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Matsuura S, Nishimura M, Iwaki N, Kashiwagi S.

Clin Infect Dis. 2009 Dec 15;49(12):1828-35. doi: 10.1086/648424.

PMID:
19911968
7.

Utility of Maoto in an influenza season where reduced effectiveness of oseltamivir was observed - a clinical, non-randomized study in children.

Toriumi Y, Kamei T, Murata K, Takahashi I, Suzuki N, Mazda O.

Forsch Komplementmed. 2012;19(4):179-86. doi: 10.1159/000341547. Epub 2012 Aug 20.

PMID:
22964983
8.

A comparison of the effectiveness of zanamivir and oseltamivir for the treatment of influenza A and B.

Kawai N, Ikematsu H, Iwaki N, Maeda T, Kanazawa H, Kawashima T, Tanaka O, Yamauchi S, Kawamura K, Nagai T, Horii S, Hirotsu N, Kashiwagi S.

J Infect. 2008 Jan;56(1):51-7. Epub 2007 Oct 15.

PMID:
17936910
9.

Administration of neuraminidase inhibitors for the treatment of Japanese patients infected with the novel influenza A (H1N1).

Ohnishi K, Nakamura-Uchiyama F.

J Infect Chemother. 2010 Feb;16(1):62-3. doi: 10.1007/s10156-009-0006-3.

PMID:
20072797
10.

[Role of neuraminidase inhibitors for the treatment of influenza A virus infections].

Ferraris O, Escuret V, Bouscambert-Duchamp M, Lina B, Morfin F.

Pathol Biol (Paris). 2010 Apr;58(2):e69-78. doi: 10.1016/j.patbio.2010.01.011. Epub 2010 Mar 19. Review. French.

PMID:
20303677
11.

Antiviral therapy and prophylaxis for influenza in children.

American Academy of Pediatrics Committee on Infectious Diseases.

Pediatrics. 2007 Apr;119(4):852-60. Review.

PMID:
17403862
12.

Resistance to neuraminidase inhibitors.

Dolin R.

Clin Infect Dis. 2011 Feb 15;52(4):438-9. doi: 10.1093/cid/ciq184. Epub 2011 Jan 19. No abstract available.

PMID:
21248366
13.

Laninamivir octanoate: a new long-acting neuraminidase inhibitor for the treatment of influenza.

Ikematsu H, Kawai N.

Expert Rev Anti Infect Ther. 2011 Oct;9(10):851-7. doi: 10.1586/eri.11.112. Review.

PMID:
21973296
14.

Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis.

Hayden FG, Belshe R, Villanueva C, Lanno R, Hughes C, Small I, Dutkowski R, Ward P, Carr J.

J Infect Dis. 2004 Feb 1;189(3):440-9. Epub 2004 Jan 26.

PMID:
14745701
15.

Treatment and prevention of influenza: Swedish recommendations.

Uhnoo I, Linde A, Pauksens K, Lindberg A, Eriksson M, Norrby R; Swedish Consensus Group.

Scand J Infect Dis. 2003;35(1):3-11. Review.

PMID:
12685876
16.

Antivirals for the treatment and prevention of epidemic and pandemic influenza.

Oxford JS.

Influenza Other Respir Viruses. 2007 Jan;1(1):27-34. doi: 10.1111/j.1750-2659.2006.00006.x. Review.

17.

Neuraminidase inhibitors for treatment and prophylaxis of influenza in children: systematic review and meta-analysis of randomised controlled trials.

Shun-Shin M, Thompson M, Heneghan C, Perera R, Harnden A, Mant D.

BMJ. 2009 Aug 10;339:b3172. doi: 10.1136/bmj.b3172. Review.

18.

Antiviral management of seasonal and pandemic influenza.

Hayden FG, Pavia AT.

J Infect Dis. 2006 Nov 1;194 Suppl 2:S119-26.

PMID:
17163384
19.

[Effect of post-exposure prophylaxis with oseltamivir for those in contacts with influenza patients in pediatric wards].

Shinjoh M, Sato S, Sugaya N, Mitamura K, Takeuchi Y, Kosaki K, Takahashi T.

Kansenshogaku Zasshi. 2004 Mar;78(3):262-9. Japanese.

PMID:
15103909
20.

[Controversies about neuraminidase inhibitor. Is the influenza drug less effective than assumed?].

Haas W.

MMW Fortschr Med. 2010 Jan 21;152(3):7. German. No abstract available.

PMID:
20333956

Supplemental Content

Support Center